Clinical Trial Update: A Safety and Bioequivalence of a Mometasone Nasal Spray, 50 mcg/Actuation Compared With Nasonex® Nasal Spray 50 mcg/Actuation in the Relief of the Symptoms of Seasonal Allergic Rhinitis (SAR) [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing mometasone nasal spray to Nasonex nasal spray for relief of seasonal allergic rhinitis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Nasonex (mometasone furoate)
• mometasone nasal spray (mometasone)

Snippet

Sponsor: Padagis LLC | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED